Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: BostonView who wrote (7491)	10/16/1998 3:05:00 PM
From: aknahow	Respond to of 17367

BostonView, people believe that there is not much letter writer support for XOMA but this is not true. Think there are about 7 "letters" that recommend it. Obviously these recommendations have not done much good. Broker recommendations many times depend on the existence of an underwriting relationship, rather than a real view of the prospects for the company. But, in the real world these are the recommendations that count the most. This is one reason I like Eisingers articles at TSC, or thestreet.com as he always makes the bias of those quoted clear. He does not recommend stocks but his articles provide information on the real issues facing a company. I think that the Discover article may stimulate other similar publications to at least look into XOMA and BPI since they were mentioned as one being farther down the long hard road, (my words), to approval. But since so many other companies were mentioned I am not sure that who others write about will be that easy to determine.